This arm of the mechanism is also believed to drive PCSK9 degradation, which appears to lower LDL cholesterol in clinical readouts
In general, fatigue may start to improve after 2 to 4 weeks of consistent use
Beginning with the EMPA-REG OUTCOME trial in 2015, multiple glucose-lowering therapies have demonstrated a reduction in cardiovascular outcomes in people both with and without T2D
doi:10.2337/db15-1255 17
Furthermore, transferring neutrophils from mice with periodontitis into diabetic mice reproduced these effects, confirming that inflammatory BM neutrophils contributed directly to disease progression
doi: 10.3389/fendo.2026.1784709 Received 10 January 2026 Revised 30 January 2026 Accepted 30 January 2026 Published 18 February 2026 Volume 17 - 2026 Edited by Marcia Hiriart, Universidad Nacional Autonoma de Mexico, Mexico Reviewed by Jialin Fan, Rutgers, The State University of New Jersey, United States Kei Shing Ng, The University of Hong Kong, Hong Kong SAR, China Updates Copyright 2026 Liu, Ren, Zhang and Ma